Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Gross Profit (2016 - 2025)

Phibro Animal Health has reported Gross Profit over the past 14 years, most recently at $132.7 million for Q4 2025.

  • Quarterly results put Gross Profit at $132.7 million for Q4 2025, up 30.22% from a year ago — trailing twelve months through Dec 2025 was $467.0 million (up 32.63% YoY), and the annual figure for FY2025 was $399.9 million, up 27.74%.
  • Gross Profit for Q4 2025 was $132.7 million at Phibro Animal Health, up from $119.8 million in the prior quarter.
  • Over the last five years, Gross Profit for PAHC hit a ceiling of $132.7 million in Q4 2025 and a floor of $64.7 million in Q3 2021.
  • Median Gross Profit over the past 5 years was $77.9 million (2022), compared with a mean of $84.4 million.
  • Biggest five-year swings in Gross Profit: decreased 2.24% in 2023 and later skyrocketed 43.46% in 2025.
  • Phibro Animal Health's Gross Profit stood at $70.7 million in 2021, then rose by 9.5% to $77.4 million in 2022, then increased by 1.59% to $78.6 million in 2023, then rose by 29.58% to $101.9 million in 2024, then soared by 30.22% to $132.7 million in 2025.
  • The last three reported values for Gross Profit were $132.7 million (Q4 2025), $119.8 million (Q3 2025), and $110.0 million (Q2 2025) per Business Quant data.